Neutron Stimulated Emission Computed Tomography (NSECT) for Early Detection of Breast Cancer

• Main Authors: Kapadia, A.J., Sharma, A.C., Tourassi, G.D., Bender, J.E., Crowell, A.S., Kiser, M.R., Howell, C.R., Floyd, C.E.
• Format: Conference Proceeding
• Language: English
• Subjects: Breast cancer; Cancer detection; Computed tomography; Electromagnetic scattering; Gamma ray detection; Gamma ray detectors; Humans; Neutrons; Spectroscopy; Stimulated emission
• ISSN: 1082-3654; 2577-0829
• DOI: 10.1109/NSSMIC.2006.353847

Neutron stimulated emission computed tomography (NSECT) is being developed as a non-invasive spectroscopic technique to determine element concentrations in the human body. We have implemented an NSECT system that uses a beam of high-energy neutrons to identify element concentrations in tissue and create 2-dimensional maps of elemental distribution through a single non-invasive tomographic scan. Neutrons scatter inelastically with atomic nuclei in tissue, causing them to emit characteristic gamma photons. These gamma photons are detected and identified using an energy-sensitive gamma detector. By measuring the energy and number of emitted gamma photons, the system can determine the elemental composition of the target tissue. NSECT has the advantage of being able to detect breast cancer at very early stages compared to anatomic screening techniques, as it detects changes in trace element concentrations in the breast, which usually occur before anatomical features such as tumors and micro-calcifications appear. The tomographic scanning system eliminates the need for breast compression and patient disrobing. The system design can be made portable by using a commercially available portable neutron source with a gamma detector. From our preliminary results, NSECT shows significant promise in early diagnosis of breast cancer. It has the potential to evolve into an easily accessible screening modality and diagnostic technique for breast cancer, which can detect and identify malignant tissue in the breast and generate a two-dimensional image through a single non-invasive tomographic scan. Patient dose levels from NSECT are comparable to those of screening mammography. Efforts are under way to achieve the micro-gram sensitivity required for in-vivo trace element detection in the breast at the lowest possible patient dose levels. Our final goal is to implement a portable, low-dose tomographic screening system for breast cancer which does not require breast compression or invasive biopsies.